QIAGEN acquires additional PCR licenses from Roche and Idaho Technology
QIAGEN announced that it has acquired additional licenses from Roche and Idaho Technology related to the use of instrumentation and reagents for PCR-based molecular testing. Financial details were not disclosed.
The agreements cover thermal cycler rights and real-time polymerase chain reaction (PCR) methods for diagnostics and all other applications. In addition, the agreements also cover rights for "high resolution melting curve analysis" (HRM) technology. This novel PCR technology, which is well leveraged by QIAGEN's detection platform Rotor-Gene(TM) Q, opens up a broad array of applications such as mutation discovery, pathogen detection and methylation analysis, as it adds a further information dimension into traditional real time PCR.
With these agreements QIAGEN becomes the first Idaho Technology/ Roche licensee to have full freedom to offer HRM related instruments and reagents under license in all formats and for all purposes in research and diagnostics worldwide. The agreements complement previous settlement arrangements following QIAGEN's 2008 acquisition of Australian PCR cycler manufacturer Corbett.
Other news from the department business & finance
Most read news
More news from our other portals
See the theme worlds for related content
Last viewed contents
LIMAA Technologies and Labor Becker announce strategic partnership - Better generate, manage and analyze histopathology data on a large scale
Research that more than meets the eye - New Technique Analyses Blood Flow in Glaucoma Patients
Filming antibiotic resistance in Slow-Motion - X-ray laser European XFEL captures rapid reaction of bacterial enzyme
Bacteria-based biohybrid microrobots on a mission to one day battle cancer - Scientists add artificial components to bacteria for better control and an extra therapeutic effect in seeking and destroying tumor cells
LAUDA appoints Dr. Ralf Hermann as the new General Manager Constant temperature equipment
Screening proteins to expose early signs of illness - Matthias Mann named European Inventor Award 2019 finalist
Analytica Vietnam 2021 postponed from April to October - Exhibitors thus will be able to better plan their trade fair participation
Protein content as a marker for response to therapy in brain cancer - Look into the future in fact seems possible
World Finance 100 Award for Carl Zeiss Microscopy - The Carl Zeiss Microscopy business group is one of the world's 100 financially most successful companies
Analytica 2020 is postponed - New date in the fall of 2020
